Kymera Therapeutics (KYMR) Metrics: History & Chart

Kymera Therapeutics, Inc.(KYMR)

Biotechnology · Watertown, MA

$106.17-3.68 (-3.35%)

Delayed quote: Oct 6, 2026, 11:35 AM EDT

About Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.

Watertown, MA

273 employees

www.kymeratx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Nello Mainolfi

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-1.92%
30D Total Return	-6.42%
YTD Total Return	+41.18%
1Y Total Return	+89.72%
3Y Total Return	+598.31%
5Y Total Return	+78.67%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+41.18%
2025	+93.41%
2024	+58.01%
2023	+2.00%
2022	-60.69%
2021	+2.40%
2020

CAGR TTM	+89.15%
CAGR 3Y	+91.11%
CAGR 5Y	+12.31%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

KYMR Valuation Metrics

KYMR Stock Price Metrics

KYMR Dividend Metrics

KYMR Growth Rate Metrics

KYMR Discounted Cash Flow Metrics

KYMR Returns By Period

KYMR Yearly Returns

KYMR Average Annual Returns By Period (CAGR)

KYMR Revenue Metrics

KYMR PE Ratio Metrics

KYMR PS Ratio Metrics

KYMR PB Ratio Metrics

KYMR Price to Free Cash Flow Ratio Metrics

KYMR Debt to Equity Ratio Metrics

KYMR PEG Ratio Metrics

KYMR FCF Yield

KYMR Earnings Yield

KYMR EBITDA Yield

KYMR OCF Yield

KYMR EV/EBIT Ratio Metrics

KYMR EV/EBITDA Ratio Metrics

KYMR EV/Assets Ratio Metrics

KYMR EV/Sales Ratio Metrics

KYMR Current Ratio Metrics

KYMR Quick Ratio Metrics

KYMR ROIC Metrics

KYMR Return on Assets Metrics

KYMR Return on Equity Metrics

KYMR Net Profit Margin Metrics

KYMR Gross Profit Margin Metrics

KYMR Tax Rate Metrics

PS Ratio	102.72
PS Ratio Avg TTM	152.84
PS Ratio Avg 3Y	78.68
Current VS TTM Avg	-32.79%
Current VS 3Y Avg	+30.55%
Current VS 5Y Avg	+164.71%

PB Ratio	7.15
PB Ratio Avg TTM	6.20
PB Ratio Avg 3Y	4.70
Current VS TTM Avg	+15.29%
Current VS 3Y Avg	+52.19%
Current VS 5Y Avg	+69.83%

PFCF Ratio	53.68
PFCF Ratio Avg TTM	34.88
PFCF Ratio Avg 3Y	34.77
Current VS TTM Avg	+53.91%
Current VS 3Y Avg	+54.37%
Current VS 5Y Avg	+54.37%

Debt/Equity Ratio	0.05
Debt/Equity Ratio Avg TTM	0.07
Debt/Equity Ratio Avg 3Y	0.10
Current VS TTM Avg	-18.89%
Current VS 3Y Avg	-44.15%
Current VS 5Y Avg	-41.06%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	1.86%
FCF Yield Avg TTM	3.13%
FCF Yield Avg 3Y	3.14%
Current VS TTM Avg	-40.63%
Current VS 3Y Avg	-40.85%
Current VS 5Y Avg	-40.85%

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	6.53
Ev/Assets Ratio Avg TTM	5.47
Ev/Assets Ratio Avg 3Y	3.71
Current VS TTM Avg	+19.41%
Current VS 3Y Avg	+76.22%
Current VS 5Y Avg	+102.05%

Ev/Sales Ratio	102.32
Ev/Sales Ratio Avg TTM	150.52
Ev/Sales Ratio Avg 3Y	77.55
Current VS TTM Avg	-32.02%
Current VS 3Y Avg	+31.94%
Current VS 5Y Avg	+166.30%

Current Ratio	9.83
Current Ratio Avg TTM	9.36
Current Ratio Avg 3Y	8.24
Current VS TTM Avg	+5.00%
Current VS 3Y Avg	+19.28%
Current VS 5Y Avg	+38.97%

Quick Ratio	9.91
Quick Ratio Avg TTM	9.38
Quick Ratio Avg 3Y	8.25
Current VS TTM Avg	+5.65%
Current VS 3Y Avg	+20.14%
Current VS 5Y Avg	+39.99%

ROIC	(22.30%)
ROIC Avg 3Y	(27.65%)
ROIC Avg 5Y	(26.65%)
Current VS 3Y Avg	+19.36%
Current VS 5Y Avg	+16.33%
Current VS 10Y Avg	+11.84%

ROA	(18.21%)
ROA Avg TTM	(5.42%)
ROA Avg 3Y	(5.92%)
Current VS TTM Avg	-236.08%
Current VS 3Y Avg	-207.75%
Current VS 5Y Avg	-203.59%

ROE	(19.85%)
ROE Avg TTM	(23.91%)
ROE Avg 3Y	(27.41%)
Current VS TTM Avg	+16.99%
Current VS 3Y Avg	+27.57%
Current VS 5Y Avg	+27.75%

Net Profit Margin	(285.41%)
Net Profit Margin Avg TTM	(1395.86%)
Net Profit Margin Avg 3Y	(536.94%)
Current VS TTM Avg	+79.55%
Current VS 3Y Avg	+46.85%
Current VS 5Y Avg	+21.70%

Gross Profit Margin	101.98%
Gross Pft Margin Avg TTM	92.95%
Gross Pft Margin Avg 3Y	100.00%
Current VS TTM Avg	+9.72%
Current VS 3Y Avg	+1.98%
Current VS 5Y Avg	+1.98%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	+100.00%